What is the appropriate evaluation and management for a 10‑day postpartum woman presenting with anxiety, palpitations, and insomnia?

Management of Postpartum Anxiety with Palpitations and Insomnia at Day 10

Screen this patient immediately for anxiety using a validated tool (such as the Edinburgh Postnatal Depression Scale or GAD-7), evaluate for thyroid dysfunction and other medical causes of palpitations, and initiate cognitive behavioral therapy for insomnia (CBT-I) as the first-line intervention, as insomnia is both a predictor and modifiable risk factor for postpartum anxiety and depression.

Initial Evaluation

Screening and Diagnosis

The Women's Preventive Services Initiative (WPSI) explicitly recommends screening for anxiety in postpartum women, as anxiety disorders increase in both frequency and severity during this period 1. At day 10 postpartum, this patient requires:

• Formal anxiety screening using validated tools (Edinburgh Postnatal Depression Scale can screen for both anxiety and depression simultaneously) 1
• Rule out medical causes before attributing symptoms purely to anxiety:
  • Thyroid function tests (postpartum thyroiditis can present with anxiety, palpitations, and insomnia)
  • Basic metabolic panel
  • Complete blood count (anemia is common postpartum and can cause palpitations)
  • ECG if palpitations are prominent or concerning 1

Recognition of the Insomnia-Anxiety Connection

The triad of anxiety, palpitations, and insomnia in this patient is particularly significant. Insomnia is now recognized as an important predictor, comorbidity, and poor prognostic factor in postpartum depression and anxiety 2. Recent evidence demonstrates that shorter sleep duration predicts subsequent increases in perinatal anxiety, and those with insomnia symptoms report higher anxiety levels 3. This makes insomnia a critical therapeutic target, not just a symptom to tolerate.

Treatment Algorithm

First-Line: Target Insomnia with CBT-I

Cognitive behavioral therapy for insomnia (CBT-I) should be initiated immediately as it has demonstrated efficacy in both preventing and treating postpartum anxiety and depression 4, 5. The evidence is compelling:

• CBT-I delivered during pregnancy and postpartum reduced prenatal insomnia (very large effect) and prevented postpartum insomnia (medium effect) 4
• In postpartum women with established insomnia, CBT-I produced significantly greater reductions in insomnia severity compared to treatment-as-usual, with effects maintained at one-month follow-up 5
• Treating insomnia may be a better therapeutic target than antidepressants for preventing or treating postpartum depression, which is heterogeneous and may be more responsive to interventions addressing this common early symptom 6

CBT-I can be delivered via therapist-assisted digital materials and telephone, making it accessible even in the early postpartum period 5.

Concurrent Anxiety Management

While addressing insomnia, simultaneously treat the anxiety:

Psychotherapy (specifically cognitive behavioral therapy for anxiety) is the initial treatment for most patients 1. This should be initiated promptly given the day 10 presentation. The guideline explicitly states that CBT and other forms of psychotherapy are first-line, with medications being secondary 1.

Medication Considerations

If symptoms are severe enough to significantly impair functioning, or if psychotherapy alone is insufficient:

• SSRIs or SNRIs are the medication classes of choice when pharmacotherapy is needed 1
• The decision should balance symptom severity, functional impairment, risks of untreated illness, and medication risks during lactation 7
• At day 10 postpartum, most patients will be breastfeeding, which requires consideration of medication transfer into breast milk

Critical Clinical Pitfalls

Don't Miss Medical Causes

The most dangerous pitfall is attributing all symptoms to anxiety without ruling out:

• Postpartum thyroiditis (can present with hyperthyroid phase causing anxiety, palpitations, insomnia)
• Peripartum cardiomyopathy (rare but life-threatening)
• Severe anemia
• Substance use (including excessive caffeine intake while sleep-deprived)

Don't Dismiss Insomnia as "Normal"

While sleep disruption from infant care is expected, insomnia symptoms represent a modifiable risk factor that predicts worsening anxiety and development of postpartum depression 3, 8. Dismissing it as "just part of being a new mother" misses a critical intervention window.

Screen for Comorbid Depression

Anxiety and depression frequently co-occur in the postpartum period, with an estimated 56% of patients with major depressive disorder also having anxiety disorders 1. Screen for both simultaneously.

Assess for Obsessive-Compulsive Symptoms

Shorter sleep duration predicts increases in obsessive beliefs, and obsessive-compulsive disorder can present de novo or worsen in the peripartum period 7, 3. Ask specifically about intrusive thoughts about infant harm, which are common but distressing.

Monitoring and Follow-up

• Close follow-up within 1-2 weeks to assess treatment response
• Reassess anxiety and insomnia symptoms using the same validated tools
• Monitor for progression to postpartum depression
• Evaluate maternal-infant bonding and infant care capacity
• Adjust treatment intensity based on response

Why This Approach Prioritizes Outcomes

This recommendation prioritizes quality of life and prevention of morbidity by:

1. Targeting insomnia as a modifiable risk factor that predicts worsening anxiety and depression
2. Using evidence-based psychotherapy as first-line treatment (CBT-I and CBT for anxiety)
3. Preventing progression to more severe postpartum depression, which has adverse consequences for both mother and infant 2
4. Ruling out life-threatening medical conditions that can mimic anxiety

The evidence strongly supports that early identification and treatment of insomnia and anxiety in the postpartum period improves maternal health outcomes and mother-infant relationships 2, 9.